A FREE national cyber-safety helpline number has been launched, which anyone who suffers a threat to their online security can ring. The three-digit number is also for reporting internet fraud, phishing, hack attacks or...
Spanish scientists develop vaccine to prevent Alzheimer's
By thinkSPAIN Team Fri, Sep 16, 2011
A group of scientists from the Euroespes biomedical research centre in Galicia, lead by Dr Ramón Cacabelos, have developed the first preventative vaccine against Alzheimer's, and have applied for a patent with the US Patent Office.
"It's another step forward in the fight against the illness", said Dr Cacabelos in today's press conference.
The vaccine, known as EE-AD-SP1 and tested on genetically modified rats, allows the process of brain death - which begins as soon as the brain reaches maturity at the age of 30 - to be intercepted, thus preventing it from developing again in old age.
The vaccine has also shown itself to be effective in reduce pathogenic features of the disease in animals with signs of cerebral degeneration.
The vaccine, which is given in two separate doses, introduces a new immunogen which promotes the generation of antibodies to fight the amyloid plaques where beta-amyloid proteins accumulate in the brain of Alzheimer patients.
The drug, presented in sphingosine-1-phosphate rich liposomes that contribute to the regeneration of neurones, also impedes intracranial haemorrhages and side effects of other Alzheimer medicines.
This twin purpose - therapeutic and preventative - makes this vaccine a new weapon in the fight against the disease and could benefit both people at high risk of developing the illness, as well as those who already show symptoms of it.
Once it has been accepted by the US Patent Office, the vaccine will be clinically developed overseas, most probably in the United States. "Europe is slow when it comes to developing new drugs", said Cacabelos.
The Euroespes group, which has spent 20 years developing drugs to treat Alzheimer's, believes that the vaccine could be ready for dispensing in six to eight years.
Alzheimer's is currently the third biggest health problem in the world and the fifth largest cause of death amongst the over 65s in the United States. In the European Union, dementia care and treatment costs taxpayers 160 billion euros a year, with an average cost of 22,000 euros per patient.
You may also be interested in ...
More Technology/Science content
SPANISH-MADE technology will be used for the next mission to Mars, planned for 2020, in what will be a huge year for national science – especially for researchers based in Valladolid (Castilla y León). Two unmanned...
A GLOBAL study on anti-depressant use in which Spain took part has shown that these highly-prescribed drugs are, in fact, safe, even long-term. Published in the journal , the investigation is 'without doubt the most...
AS WELL as being world-famous for possessing one of the top public health services on earth and perpetual number one globally for transplant operations per inhabitant, Spain is also home to – and the birthplace of –...